Cart
sales@molnova.com
Nimotuzumab
CAS No. 828933-51-3
Nimotuzumab ( —— )
Catalog No. M22154 CAS No. 828933-51-3
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
Biological Information
-
Product NameNimotuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
DescriptionNimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number828933-51-3
-
Formula Weight148 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li J. Roovers, et al.Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line.Oncol Lett.2019 Mar;17(3):2763-2769.
molnova catalog
related products
-
PF-06747775
A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively.
-
SU5402
SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
-
Lapatinib
A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
